BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10545644)

  • 21. Induction of immune-mediated hearing loss in SCID mice by injection of MRL/lpr mouse spleen cells.
    Iwai H; Tomoda K; Hosaka N; Miyashima S; Suzuka Y; Ikeda H; Lee S; Inaba M; Ikehara S; Yamashita T
    Hear Res; 1998 Mar; 117(1-2):173-7. PubMed ID: 9557987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Audiological test results of the autoimmune sensorineural hearing loss].
    Gu R; Zou J; Yu L
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(1):20-3. PubMed ID: 7598979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmune mouse antibodies recognize multiple antigens proposed in human immune-mediated hearing loss.
    Hefeneider SH; McCoy SL; Hausman FA; Trune DR
    Otol Neurotol; 2004 May; 25(3):250-6. PubMed ID: 15129101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrastructural pathology in the stria vascularis of the MRL-Fasl(lpr) mouse.
    Ruckenstein MJ; Keithley EM; Bennett T; Powell HC; Baird S; Harris JP
    Hear Res; 1999 May; 131(1-2):22-8. PubMed ID: 10355601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratympanic steroid prevents long-term spiral ganglion neuron loss in experimental meningitis.
    Worsøe L; Brandt CT; Lund SP; Ostergaard C; Thomsen J; Cayé-Thomasen P
    Otol Neurotol; 2010 Apr; 31(3):394-403. PubMed ID: 20147868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term (16-26 years) follow-up outcome of steroid therapy in refractory autoimmune sensorineural hearing loss.
    Nishimura T; Okayasu T; Hosoi H; Kitahara T
    J Autoimmun; 2021 Jul; 121():102664. PubMed ID: 34049153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azathioprine in combination with steroids in the treatment of autoimmune inner-ear disease.
    Saraçaydin A; Katircioglu S; Katircioglu S; Karatay MC
    J Int Med Res; 1993; 21(4):192-6. PubMed ID: 8112477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroid-dependent sensorineural hearing loss in a patient with Charcot-Marie-Tooth disease showing auditory neuropathy.
    Maeda Y; Kataoka Y; Sugaya A; Kariya S; Kobayashi K; Nishizaki K
    Auris Nasus Larynx; 2015 Jun; 42(3):249-53. PubMed ID: 25440412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relations between cochlear histopathology and hearing loss in experimental cochlear implantation.
    O'Leary SJ; Monksfield P; Kel G; Connolly T; Souter MA; Chang A; Marovic P; O'Leary JS; Richardson R; Eastwood H
    Hear Res; 2013 Apr; 298():27-35. PubMed ID: 23396095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cochlear and renal pathology in the autoimmune strain mouse.
    Tago C; Yanagita N
    Ann Otol Rhinol Laryngol Suppl; 1992 Oct; 157():87-91. PubMed ID: 1416660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of autoimmune hearing loss in MRL/lpr mice by bone marrow transplantation.
    Lee S; Iwai H; Sugiura K; Takeuchi K; Kushida T; Tomoda K; Inaba M; Yamashita T; Ikehara S
    Bone Marrow Transplant; 2000 Oct; 26(8):887-92. PubMed ID: 11081390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic steroid reduces long-term hearing loss in experimental pneumococcal meningitis.
    Worsøe L; Brandt CT; Lund SP; Østergaard C; Thomsen J; Cayé-Thomasen P
    Laryngoscope; 2010 Sep; 120(9):1872-9. PubMed ID: 20717948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune abnormality affects ovulation and oocyte-pick-up in MRL/MpJ-Fas
    Hosotani M; Ichii O; Nakamura T; Kanazawa SO; Elewa YHA; Kon Y
    Lupus; 2018 Jan; 27(1):82-94. PubMed ID: 28566018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cochlear immunoglobulin in the C3H/lpr mouse model for autoimmune hearing loss.
    Trune DR
    Otolaryngol Head Neck Surg; 1997 Nov; 117(5):504-8. PubMed ID: 9374175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss.
    Van Wijk F; Staecker H; Keithley E; Lefebvre PP
    Audiol Neurootol; 2006; 11(6):357-65. PubMed ID: 16988499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune disease and cochlear pathology in the C3H/lpr strain mouse.
    Trune DR; Craven JP; Morton JI; Mitchell C
    Hear Res; 1989 Mar; 38(1-2):57-66. PubMed ID: 2708160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRL/MpJ-Fas(lpr) mice show abnormalities in ovarian function and morphology with the progression of autoimmune disease.
    Otani Y; Ichii O; Otsuka-Kanazawa S; Chihara M; Nakamura T; Kon Y
    Autoimmunity; 2015; 48(6):402-11. PubMed ID: 25857350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normal cochlear function in mdx and mdx(Cv3) Duchenne muscular dystrophy mouse models.
    Pillers DA; Duncan NM; Dwinnell SJ; Rash SM; Kempton JB; Trune DR
    Laryngoscope; 1999 Aug; 109(8):1310-2. PubMed ID: 10443839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term audiometric follow-up of click-evoked auditory brainstem response in hearing-impaired infants.
    Schoonhoven R; Lamoré PJ; de Laat JA; Grote JJ
    Audiology; 2000; 39(3):135-45. PubMed ID: 10905399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Auditory system involvement in late onset Pompe disease: a study of 20 Italian patients.
    Musumeci O; Catalano N; Barca E; Ravaglia S; Fiumara A; Gangemi G; Rodolico C; Sorge G; Vita G; Galletti F; Toscano A
    Mol Genet Metab; 2012 Nov; 107(3):480-4. PubMed ID: 22958975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.